TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma

Published:2023-02-23 Issue:6 Volume:30 Page:3363-3373
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Lima Henrique A.,Moazzam Zorays,Endo Yutaka,Alaimo Laura,Shaikh Chanza,Munir Muhammad Musaab,Resende Vivian,Guglielmi Alfredo,Marques Hugo P.,Cauchy François,Lam Vincent,Poultsides George A.,Popescu Irinel,Alexandrescu Sorin,Martel Guillaume,Hugh Tom,Endo Itaru,Kitago Minoru,Shen Feng,Pawlik Timothy M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-13273-1.pdf

Reference44 articles.

1. Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765–79. https://doi.org/10.1586/17474124.2015.1028363.

2. Koniaris LG, Levi DM, Pedroso FE, et al. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg. 2011;254(3):527–37. https://doi.org/10.1097/SLA.0b013e31822ca66f. (discussion 537-8).

3. Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. https://doi.org/10.1038/s41572-020-00240-3.

4. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233(5):652–9. https://doi.org/10.1097/00000658-200105000-00009.

5. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002;8(10):873–83. https://doi.org/10.1053/jlts.2002.34923.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma;HPB;2024-08

2. Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-07

3. Inflammatory indicators such as systemic immune inflammation index (SIII), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic factors of curative hepatic resections for hepatocellular carcinoma;Hepatobiliary Surgery and Nutrition;2024-06

4. New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm;International Journal of Clinical Oncology;2024-05-20

5. Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score;BMC Cancer;2024-03-06